Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Invested Capital (2016 - 2025)

Orthofix Medical's Invested Capital history spans 17 years, with the latest figure at $450.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital fell 10.55% year-over-year to $450.0 million, compared with a TTM value of $450.0 million through Dec 2025, down 10.55%, and an annual FY2025 reading of $450.0 million, down 10.55% over the prior year.
  • Invested Capital for Q4 2025 was $450.0 million at Orthofix Medical, up from $442.5 million in the prior quarter.
  • The five-year high for Invested Capital was $664.2 million in Q1 2023, with the low at $333.5 million in Q3 2022.
  • Average Invested Capital over 5 years is $463.7 million, with a median of $454.2 million recorded in 2025.
  • Year-over-year, Invested Capital skyrocketed 97.92% in 2023 and then decreased 20.08% in 2025.
  • Tracing OFIX's Invested Capital over 5 years: stood at $354.1 million in 2021, then decreased by 4.6% to $337.9 million in 2022, then soared by 77.58% to $600.0 million in 2023, then fell by 16.14% to $503.1 million in 2024, then decreased by 10.55% to $450.0 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Invested Capital are $450.0 million (Q4 2025), $442.5 million (Q3 2025), and $458.3 million (Q2 2025).